Work

Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-168303

Authors: Ahmad Ghorab, Mark R. Litzow, Naseema Gangat, Aref Al-Kali, Mithun V. Shah, Hemant S. Murthy, Ayalew Tefferi, Hassan B. Alkhateeb, Kebede Begna, Mrinal M. Patnaik, James M. Foran, Talha Badar

Institutions: Mayo Clinic in Florida, Mayo Clinic

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310108996

FWCI: 0.179

Cites:

Cited by: 1

Related to: 10